<PAGE>
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-----------
AMENDMENT NO. 1
TO
SCHEDULE 14D-1
TENDER OFFER STATEMENT PURSUANT TO
SECTION 14(1) OF THE SECURITIES EXCHANGE ACT OF 1934
-----------
AMERICAN MEDICAL RESPONSE, INC.
(Name of Subject Company)
MEDTRANS ACQUISITION CO.
LAIDLAW INC.
(Bidders)
COMMON STOCK, PAR VALUE $.01 PER SHARE
(Title of Class of Securities)
027446 10 3
(Cusip Number of Class of Securities)
-----------
IVAN R. CAIRNS
SENIOR VICE PRESIDENT AND GENERAL COUNSEL
LAIDLAW INC.
3221 NORTH SERVICE ROAD
BURLINGTON, ONTARIO L7R 3Y8
(Name, Address and Telephone Number of Person Authorized
to Receive Notices and Communications on Behalf of Bidders)
-----------
Copy to:
STEPHEN J. DRAGICH
SCHIFF HARDIN & WAITE
7200 SEARS TOWER
CHICAGO, ILLINOIS
(312) 258-5692
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
<PAGE>
AMENDMENT NO. 1
TO
SCHEDULE 14D-1
This Amendment No. 1 to Tender Offer Statement on Schedule 14D-1 relates to
the offer by MedTrans Acquisition Co. (the "Purchaser"), a Delaware corporation
and a wholly-owned subsidiary of Laidlaw Inc., a Canadian corporation
("Laidlaw"), to purchase all of the outstanding shares of common stock, par
value $.01 per share (the "Shares"), of American Medical Response, Inc. at a
purchase price of $40.00 per Share, net to the seller in cash, without interest
thereon, upon the terms and subject to the conditions set forth in the Offer to
Purchase dated January 10, 1997, and in the related Letter of Transmittal. The
item numbers and responses thereto below are in accordance with the requirements
of Schedule 14D-1.
ITEM 11. MATERIAL TO BE FILED AS EXHIBITS.
(a)(8) Press Released issued January 24, 1997.
<PAGE>
SIGNATURE
After due inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
Dated: January 24, 1997 MEDTRANS ACQUISITION CO.
By: /s/ Ivan R. Cairns
-------------------------------
Its: Senior Vice President
------------------------------
LAIDLAW INC.
By: /s/ Ivan R. Cairns
-------------------------------
Its: Senior Vice President
------------------------------
<PAGE>
EXHIBIT (a)(8)
<PAGE>
LAIDLAW TO REFILE FOR AMR MERGER
January 24, 1997 . . . Burlington, Ontario. Laidlaw Inc. (NYSE:LDW.B) says that
in order to allow the Antitrust Division of the U. S. Department of Justice and
the U. S. Federal Trade Commission (FTC) sufficient time to complete the review
of its cash offer for the outstanding shares of American Medical Response Inc.
(AMR), -- (NYSE:EMT) -- it intends to refile a Pre-merger Notification and
Report Form under the Hart-Scott-Rodino Act on Monday, January 27, 1997.
A fifteen-day waiting period, for which Laidlaw has requested early termination,
is required prior to the proposed merger being consummated.
-30-
Contact: 1-800-563-6072 ext. 309
T.A.G. Watson
Vice President, Communications
